[
Webinar
|
August 16, 2022
]

ICH and Pharma 4.0: The Implications for Brazil

ICH and Pharma 4.0: The Implications for Brazil

A 60-minute cross-industry panel of experts will explore how the recently adopted International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guidelines will impact key stakeholders in the manufacturing of pharmaceutical products in Brazil.

Regulatory professionals, pharmaceutical executives, academic researchers, and other interested parties will gain an understanding of how the ICH Guidelines, Pharma 4.0 and Quality by Design principles intersect in the advancement of pharmaceutical manufacturing.

Speakers
6 photos
[
Webinar
 I
]

Every Day Counts: Raising The Bar In Gene Therapy With Science & Structure | Viralgen & QbDVision Webinar

[
Webinar
 I
]

Weaving the Digital Threads for Life Sciences

[
Webinar
 I
]

Accelerating QbD: Perspectives on Product Risk Assessments for Advanced Biologics

Sign up to learn more
Legend
Legend
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
[
Customer Story
 I
November 8, 2023
]

From Paper to 3X Faster Technology Transfers

Tech Transfer
[
Customer Story
 I
January 8, 2024
]

Streamlining CMC Workflow for Xeris Biopharma

Tech Transfer
[
Customer Story
 I
September 30, 2025
]

Transforming Tech Transfers for Big Pharma

Tech Transfer

We’re here to help you deliver

[
General Manager
]

Gustavo Mendes Lima Santos

[
Client Service Specialist
]

Sana Ahmed

[
President
]

Mario Brenga Gianpetro

[
Associate Professor in Pharmaceutics
]

Walkiria Schlindwein

[
Owner
]

Line Lundberg

[
President & CEO
]

Yash Sabharwal

Yash Sabharwal is an accomplished inventor, entrepreneur, and executive specializing in the funding and growth of early-stage technology companies focused on life science applications. He has started 3 companies and successfully exited his last two, bringing a wealth of strategic and tactical experience to the team.